Rejected at 3:09 a.m. Nov, 01, 2023 ] by Cameron
Author: FrozenCherry
Related Note: 1481330642022
Rationale for change

better use standard format ie not to mention aa and ... but rather "specific" as a hint

Rejection reason

Agree w/ Ahmed in comments; think this one needs prompting to remember its asking for specific AA AND gene

Text Text
Extra
- JAK2 (Janus Kinase 2) is a cytoplasmic tyrosine kinase located on chromosome 9

- Mutations result in myeloid progenitors developing a hypersensitivity to growth stimulating cytokines

- This results in unregulated myeloproliferation; cells have more growth and longer survival
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid

Sketchy



Watch Myeloproliferative Neoplasms & Myelodysplastic Syndromes
Sketchy 2
Empty field
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Empty field
Physeo
Empty field
Bootcamp
Watch associated Bootcamp video - Plasma Cell Dyscrasias and Myeloproliferative Disease: Polycythemia Vera and Essential Thrombocythemia

Watch associated Bootcamp video - Plasma Cell Dyscrasias and Myeloproliferative Disease: Myelofibrosis and Myelodysplastic Syndromes
OME

Additional Resources
Other:
One by one
Empty field
#AK_Original_Decks::Step_1::Zanki_Step_Decks::Zanki_Hematology_&_Oncology::Pathoma_WBC #AK_Step1_v12::#SketchyPath::10_Myeloid_&_Lymphoid::01_Myeloid_Disorders::03_Polycythemia #AK_Step1_v12::^Systems::HemeOnc::WBC #AK_Step1_v12::#UWorld::Step::15323 #AK_Step1_v12::#FirstAid::10_Hematology_and_Oncology::04_Pathology::29_Myeloproliferative_neoplasms::01_Polycythemia_vera #AK_Step1_v12::^Other::^EXPN::Boards&Beyond #AK_Step1_v12::^Other::^EXPN::Uworld #AK_Step1_v12::#Pathoma::06_WBC::04_Myeloproliferative #AK_Step1_v12::#UWorld::COMLEX::26236 #AK_Step1_v12::#FirstAid::10_Hematology_and_Oncology::04_Pathology::31_Polycythemia::*Polycythemia_Vera #AK_Step1_v12::#B&B::08_Endocrinology::05_Other::04_Signaling_Pathways::Extra #AK_Step1_v12::#Bootcamp::Hematology_and_Oncology::10_Plasma_Cell_Dyscrasias_&_Myeloproliferative_Disease::03_Polycythemia_Vera_&_Essential_Thrombocythemia #AK_Step1_v12::#FirstAid::10_Hematology_and_Oncology::04_Pathology::29_Myeloproliferative_neoplasms::*Chronic_Myeloproliferative_Disorders::Basics #AK_Step1_v12::#OME::Clinical::04_Organ_Systems::05_Hematology_Oncology::04_Proliferation::02_Myeloproliferation #AK_Step1_v12::^Other::^HighYield::1-HighYield #AK_Step1_v12::#AMBOSS::CnaqvO #AK_Step1_v12::#Physeo::11_Pathology::10_HemeOnc_Pathology::14_Myeloproliferative_Disorders #AK_Step1_v12::#UWorld::COMLEX::25437 #AK_Step2_v12::#B&B::07_Hematology_and_Oncology::03_White_Cells::02_Myeloproliferative_Disorders #AK_Step1_v12::#Bootcamp::Hematology_and_Oncology::10_Plasma_Cell_Dyscrasias_&_Myeloproliferative_Disease::04_Myelofibrosis_and_Myelodysplastic_Syndromes #AK_Step1_v12::#UWorld::Step::8591 #AK_Step1_v12::#SketchyPath::10_Myeloid_&_Lymphoid::01_Myeloid_Disorders::01_Myeloproliferative_Neoplasms_&_Myelodysplastic_Syndromes !AK_UpdateTags::Step1decks::Zanki-Step-Decks::Zanki-Hematology-&-Oncology::Pathoma-WBC #AK_Step1_v12::#OME::04_Organ_Systems::05_Hematology_Oncology::04_Proliferation::02_Myeloproliferation #AK_Step1_v12::^Other::^EXPN::BGedit